Anti-angiogenic effects of crenolanib are mediated by mitotic modulation independently of PDGFR expression

Optimization for multidrug combinations: Challenges and perspectives in complex disorders

(2019) Patrycja Nowak-Sliwinska   PHARMACOLOGICAL RESEARCH

IGF2 and IGF1R identified as novel tip cell genes in primary microvascular endothelial cell monolayers

(2018) Marchien G. Dallinga et al.   ANGIOGENESIS

Consensus guidelines for the use and interpretation of angiogenesis assays

(2018) Patrycja Nowak-Sliwinska et al.   ANGIOGENESIS

Combination of ruthenium(II)-arene complex [Ru(η6-p-cymene)Cl2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity

(2017) Robert H. Berndsen et al.   Scientific Reports

Pharmacological Inhibition of Centrosome Clustering by Slingshot-Mediated Cofilin Activation and Actin Cortex Destabilization

(2016) Gleb Konotop et al.   CANCER RESEARCH

Chromothripsis: A New Mechanism for Rapid Karyotype Evolution

(2015) Mitchell L. Leibowitz et al.   Annual Review of Genetics

SiR–Hoechst is a far-red DNA stain for live-cell nanoscopy

(2015) Gražvydas Lukinavičius et al.   Nature Communications

Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction

(2015) Esther A. Kleibeuker et al.   Cancer Medicine

The chicken chorioallantoic membrane model in biology, medicine and bioengineering

(2014) Patrycja Nowak-Sliwinska et al.   ANGIOGENESIS

The emerging quest for the optimal angiostatic combination therapy: Figure 1

(2014) Arjan W. Griffioen et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Crenolanib is a selective type I pan-FLT3 inhibitor

(2014) C. C. Smith et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants

(2013) A. Galanis et al.   BLOOD

CD34 marks angiogenic tip cells in human vascular endothelial cell cultures

(2012) Martin J. Siemerink et al.   ANGIOGENESIS

A novel and simple method for culturing pericytes from mouse brain

(2012) Ulrich Tigges et al.   MICROVASCULAR RESEARCH

Angiostatic kinase inhibitors to sustain photodynamic angio-occlusion

(2011) Patrycja Nowak-Sliwinska et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation

(2009) A. N. Stratman et al.   BLOOD

Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Oral CP-868,596, a Highly Specific Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor in Patients With Advanced Cancers

(2009) Nancy L. Lewis et al.   JOURNAL OF CLINICAL ONCOLOGY

Role of platelet-derived growth factors in physiology and medicine

(2008) J. Andrae et al.   GENES & DEVELOPMENT

The role of cytoskeleton in the regulation of vascular endothelial barrier function

(2008) Natalia V. Bogatcheva et al.   MICROVASCULAR RESEARCH

The actin cytoskeleton in endothelial cell phenotypes

(2008) Nutan Prasain et al.   MICROVASCULAR RESEARCH

A quantitative analysis of kinase inhibitor selectivity

(2008) Mazen W Karaman et al.   NATURE BIOTECHNOLOGY

Angiogenic profiling and comparison of immortalized endothelial cells for functional genomics

(2007) Judy R. van Beijnum et al.   EXPERIMENTAL CELL RESEARCH